Member Info for thomascromwell

You are right, as it is ingested.

Like a topical cream....??????

Elrico, So it's Boots then! On a another topic, surely by now Psoriasis UK must be aware of the successful use of AxisB in the treatment of Psoriasis.

Todays meaningless RNS, but no RNS issued for the redundancies of 65% of the work force and of the US litigation.

Elric, Please have a I/V with Professor O'Neil, and her insight of the skin care market and their IP in this market.

The problemo is a lack of news, at this point in time any update is more than relevant. Elric it is time to shoot the breeze with Catherine.

An update on Croda is long overdue!

if a company is not generating profit, debt and liabilities will be subtracted from the assets of the company. We will see with the audit.

If a company is not generating profit, the audit will take into consideration the assets and their current worth, this maybe crucial for the next fundraise and price.

Father Elmer, It does matter, if you have insufficient cash, the assets will be marked lower, to continue as a going concern. Which will make some sort of funding inevitable.

Mol. I hope the transformation comes from the revenues from Croda. As to the acquisition, a new managerial structure and increased staff should make the company more efficient, which is transformative.

Richetts may have shafted Amanda Sollaway and the Government in giving a 5 million tax payer funded handout to this continuing loss making enterprise, which pays it's CEO, an annual salary of 400k. The Yanks are not quite as dumb as your intelligence suggests.

At some stage an audit has to be done, otherwise, suspension will be imposed. Versarian has failed to generate profit, and as such is not a going concern, unless a sizable placing is undertaken. pdq.

What occurs before the 23rd, is either a placing or sacking of the auditors. Any answers?

Acquisition D' has a product line that sells via its marketing to various pharmacies and the NHS, skin medications that are not exceptional, but profitable. With STBX research and proven science, plus the revenue stream from Croda, which they must have been given a strong indication of, this golden opportunity has greater significance for D but also gives significant commercial traction as a combined entity with SBTX. Just a reiteration.

Choleric, The Obsequious Troll, formerly the Hen & Chicken, look forward to your continuing patronage.

News at last, and not from the Hen & Chicken!

Denial Father Elmer, Denial.

Versarian has enriched graphene incontinence pads for sale regarding its forthcoming results.

The audit will make a placing obligatory, what price will this be?